Open AccessInconsistency in the reporting of antitubercular drug susceptibility tests in an endemic region
Author(s) -
Avinandan Saha,
Preyas J Vaidya,
Vinod B Chavhan,
Kamlesh Pandey,
Arvind Kate,
Prashant N. Chhajed
Publication year - 2017
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/0970-2113.213840
Subject(s) - medicine , tuberculosis , second line , drug , ciprofloxacin , first line , pharmacology , antibiotics , pathology , biology , microbiology and biotechnology
Individualized treatment for multidrug-resistant tuberculosis (MDR TB) is associated with improved outcomes. Therapy needs to be tailored to drug susceptibility testing (DST) results. We present our observations on the inconsistency in DST reporting in an endemic region with a high prevalence of MDR TB.